Literature DB >> 27974637

Non-cell-autonomous Effects of Autophagy Inhibition in Tumor Cells Promote Growth of Drug-resistant Cells.

Jacqueline Thorburn1, Leah Staskiewicz1, Megan L Goodall1, Lina Dimberg1, Arthur E Frankel1, Heide L Ford1, Andrew Thorburn2.   

Abstract

Autophagy, the mechanism by which cells deliver material to the lysosome, has been associated with resistance to anticancer drugs, leading autophagy inhibition to be widely studied as a potential chemosensitization strategy for cancer cells. This strategy is based on the idea that inhibition of autophagy will increase drug sensitivity and kill more cancer cells. Here we report an unintended negative effect of this strategy. When modeling the effect of drug resistance in a heterogeneous cancer cell population, we found that autophagy inhibition in drug-sensitive tumor cells causes increased growth of drug-resistant cells in the population through a mechanism involving caspase activation and prostaglandin E2 signaling. These results emphasize the importance of understanding how autophagy manipulation in a tumor cell can have both cell-autonomous and nonautonomous effects and suggest that attempts to chemosensitize by inhibiting autophagy could be enhanced by adopting methods aimed at reducing tumor repopulation.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27974637      PMCID: PMC5198514          DOI: 10.1124/mol.116.106070

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  31 in total

1.  Autophagy controls the kinetics and extent of mitochondrial apoptosis by regulating PUMA levels.

Authors:  Jacqueline Thorburn; Zdenek Andrysik; Leah Staskiewicz; Jacob Gump; Paola Maycotte; Andrew Oberst; Douglas R Green; Joaquín M Espinosa; Andrew Thorburn
Journal:  Cell Rep       Date:  2014-03-27       Impact factor: 9.423

2.  Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma.

Authors:  Xiao-Hong Ma; Sheng-Fu Piao; Souvik Dey; Quentin McAfee; Giorgos Karakousis; Jessie Villanueva; Lori S Hart; Samuel Levi; Janice Hu; Gao Zhang; Rossitza Lazova; Vincent Klump; John M Pawelek; Xiaowei Xu; Wei Xu; Lynn M Schuchter; Michael A Davies; Meenhard Herlyn; Jeffrey Winkler; Constantinos Koumenis; Ravi K Amaravadi
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

Review 3.  Targeting autophagy during cancer therapy to improve clinical outcomes.

Authors:  Jean M Mulcahy Levy; Andrew Thorburn
Journal:  Pharmacol Ther       Date:  2011-03-23       Impact factor: 12.310

4.  Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.

Authors:  Antonina V Kurtova; Jing Xiao; Qianxing Mo; Senthil Pazhanisamy; Ross Krasnow; Seth P Lerner; Fengju Chen; Terrence T Roh; Erica Lay; Philip Levy Ho; Keith Syson Chan
Journal:  Nature       Date:  2014-12-03       Impact factor: 49.962

5.  Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma.

Authors:  Rebecca A Barnard; Luke A Wittenburg; Ravi K Amaravadi; Daniel L Gustafson; Andrew Thorburn; Douglas H Thamm
Journal:  Autophagy       Date:  2014-05-20       Impact factor: 16.016

6.  Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy.

Authors:  Christina H Eng; Zuncai Wang; Diane Tkach; Lourdes Toral-Barza; Savuth Ugwonali; Shanming Liu; Stephanie L Fitzgerald; Elizabeth George; Elizabeth Frias; Nadire Cochran; Rowena De Jesus; Gregory McAllister; Gregory R Hoffman; Kevin Bray; LuAnna Lemon; Judy Lucas; Valeria R Fantin; Robert T Abraham; Leon O Murphy; Beat Nyfeler
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-17       Impact factor: 11.205

Review 7.  Autophagy modulation as a potential therapeutic target for diverse diseases.

Authors:  David C Rubinsztein; Patrice Codogno; Beth Levine
Journal:  Nat Rev Drug Discov       Date:  2012-09       Impact factor: 84.694

8.  Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy.

Authors:  Qian Huang; Fang Li; Xinjian Liu; Wenrong Li; Wei Shi; Fei-Fei Liu; Brian O'Sullivan; Zhimin He; Yuanlin Peng; Aik-Choon Tan; Ling Zhou; Jingping Shen; Gangwen Han; Xiao-Jing Wang; Jackie Thorburn; Andrew Thorburn; Antonio Jimeno; David Raben; Joel S Bedford; Chuan-Yuan Li
Journal:  Nat Med       Date:  2011-07-03       Impact factor: 53.440

9.  Therapy-induced tumour secretomes promote resistance and tumour progression.

Authors:  Anna C Obenauf; Yilong Zou; Andrew L Ji; Sakari Vanharanta; Weiping Shu; Hubing Shi; Xiangju Kong; Marcus C Bosenberg; Thomas Wiesner; Neal Rosen; Roger S Lo; Joan Massagué
Journal:  Nature       Date:  2015-03-25       Impact factor: 49.962

10.  Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma.

Authors:  Reshma Rangwala; Robert Leone; Yunyoung C Chang; Leslie A Fecher; Lynn M Schuchter; Amy Kramer; Kay-See Tan; Daniel F Heitjan; Glenda Rodgers; Maryann Gallagher; Shengfu Piao; Andrea B Troxel; Tracey L Evans; Angela M DeMichele; Katherine L Nathanson; Peter J O'Dwyer; Jonathon Kaiser; Laura Pontiggia; Lisa E Davis; Ravi K Amaravadi
Journal:  Autophagy       Date:  2014-05-20       Impact factor: 16.016

View more
  4 in total

1.  Overexpression of iASPP is required for autophagy in response to oxidative stress in choriocarcinoma.

Authors:  Ka-Kui Chan; Esther Shuk-Ying Wong; Ivy Tsz-Lo Wong; Claire Ling-Yang Cheung; Oscar Gee-Wan Wong; Hextan Yuen-Sheung Ngan; Annie Nga-Yin Cheung
Journal:  BMC Cancer       Date:  2019-10-15       Impact factor: 4.430

Review 2.  Autophagy and Its Relationship to Epithelial to Mesenchymal Transition: When Autophagy Inhibition for Cancer Therapy Turns Counterproductive.

Authors:  Guadalupe Rojas-Sanchez; Israel Cotzomi-Ortega; Nidia G Pazos-Salazar; Julio Reyes-Leyva; Paola Maycotte
Journal:  Biology (Basel)       Date:  2019-09-24

3.  Mitochondrial-derived vesicles compensate for loss of LC3-mediated mitophagy.

Authors:  Christina G Towers; Darya K Wodetzki; Jacqueline Thorburn; Katharine R Smith; M Cecilia Caino; Andrew Thorburn
Journal:  Dev Cell       Date:  2021-06-24       Impact factor: 13.417

Review 4.  Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer.

Authors:  Cally J Ho; Sharon M Gorski
Journal:  Cancers (Basel)       Date:  2019-11-11       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.